The Valley Desk

ArticleCrohn's & colitis 360Published

Certolizumab Pegol Treatment in Patients With Crohn's Disease: Final Safety Data From the SECURE Registry

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Perelman School of Medicine, with University of Pennsylvania linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
Crohn's & colitis 360
Published
Subject terms
Lymphoma; Malignancy; Non-melanoma skin cancer; Crohn’s Disease; Certolizumab Pegol; Tnfi; Secure Registry
PubMed ID
39895830
PubMed Central ID
PMC11786119
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal